INS and type 2 diabetes mellitus: Heise et al. used gold standard hyperinsulinemic euglycemic and hyperglycemic clamp methods in 117 patients with T2D to confirm a significant improvement in the clamp disposition index, a measure reflecting both increased insulin secretion and sensitivity, in tirzepatide 15 mg vs. semaglutide 1 mg users at 28 weeks [75].